Edition:
United Kingdom

Adaptimmune Therapeutics PLC (ADAP.OQ)

ADAP.OQ on NASDAQ Stock Exchange Global Select Market

5.25USD
12 Dec 2018
Change (% chg)

-- (--)
Prev Close
$5.25
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
140,419
52-wk High
$14.62
52-wk Low
$4.86

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Sep '18 40.79 0.008
Jun '18 9.04 -0.078
Mar '18 8.20 -0.037
FY 2017 Dec '17 4.27 -0.049
Sep '17 27.18 -0.002
Jun '17 3.52 -0.036
Mar '17 2.86 -0.051
FY 2016 Dec '16 8.54 -0.036
Sep '16 2.42 -0.044
Jun '16 0.33 -0.052
Mar '16 2.92 -0.037
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Dec-18 8 5.72 20.00 0.00 3.73
Quarter Ending Mar-19 4 2.25 4.00 0.00 --
Year Ending Dec-18 8 62.07 78.00 50.00 52.40
Year Ending Dec-19 8 22.25 65.00 0.00 16.42
Earnings (per share)
Quarter Ending Dec-18 6 -0.32 -0.23 -0.46 -0.30
Quarter Ending Mar-19 3 -0.32 -0.26 -0.36 --
Year Ending Dec-18 5 -0.95 -0.87 -1.09 -0.81
Year Ending Dec-19 6 -1.18 -0.94 -1.45 -1.46
LT Growth Rate (%) 1 1.00 1.00 1.00 --
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 69.71 34.39
P/E High - Last 5 Yrs. -- 148.17 46.24
P/E Low - Last 5 Yrs. -- 47.84 24.59
Beta -- 1.08 0.91
Price to Sales (TTM) 44.03 49.58 6.22
Price to Book (MRQ) 3.33 10.17 5.20
Price to Tangible Book (MRQ) 3.35 13.83 6.74
Price to Cash Flow (TTM) -- 52.85 24.17
% Owned Institutions 62.37 3.75 1.78

Dividends

  Company industry sector
Dividend Yield -- 0.12 1.44
Dividend Yield - 5 Year Avg -- 0.09 1.46
Dividend 5 Year Growth Rate -- 0.79 4.94
Payout Ratio(TTM) -- 7.05 42.49

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago 973.48 130.06 8.17
Sales (TTM) vs TTM 1 Yr. Ago 48.46 47.89 6.50
Sales - 5 Yr. Growth Rate -- 22.79 10.44
EPS (MRQ) vs Qtr. 1 Yr. Ago 30.20 75.90 23.08
EPS (TTM) vs TTM 1 Yr. Ago -44.84 -- --
EPS - 5 Yr. Growth Rate -- 12.04 10.49
Capital Spending - 5 Yr. Growth Rate -- 9.25 14.59

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.18 2.28
Current Ratio (MRQ) 7.86 3.44 3.10
LT Debt to Equity (MRQ) 0.00 18.69 11.49
Total Debt to Equity (MRQ) 0.00 31.36 16.03
Interest Coverage (TTM) -- -43.32 30.57

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 56.37 54.44
Gross Margin - 5 Yr. Avg. -- 60.62 52.36
EBITD Margin (TTM) -435.08 -- --
EBITD - 5 Yr. Avg -- -109.98 13.16
Operating Margin (TTM) -457.44 -185.00 6.07
Operating Margin - 5 Yr. Avg. -- -126.42 8.47
Pre-Tax Margin (TTM) -432.60 -175.77 7.02
Pre-Tax Margin - 5 Yr. Avg. -- -132.58 8.71
Net Profit Margin (TTM) -438.00 -182.51 3.12
Net Profit Margin - 5 Yr. Avg. -- -136.98 4.91
Effective Tax Rate (TTM) -- 21.47 23.26
Effective Tax Rate - 5 Yr. Avg. -- 15.43 23.83

Efficiency

  Company industry sector
Revenue/Employee (TTM) 58,154 7,649,006 873,053,182
Net Income/Employee (TTM) -254,715 653,334 103,483,965
Receivable Turnover (TTM) 24.65 6.25 5.80
Inventory Turnover (TTM) -- 1.89 3.56
Asset Turnover (TTM) 0.07 0.32 0.95

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -28.98 6.47 11.45
Return on Assets - 5 Yr. Avg. -- 5.54 12.50
Return on Investment (TTM) -32.06 9.01 14.96
Return on Investment - 5 Yr. Avg. -- 6.87 16.23
Return on Equity (TTM) -35.60 10.15 16.52
Return on Equity - 5 Yr. Avg. -- 8.41 17.37
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % -- -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Adaptimmune Therapeutics PLC

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week -8.62 -11.77 35 98
13 Week 66.87 58.74 99 94
26 Week 43.16 32.28 99 98
52 Week 20.18 1.86 99 68
YTD 101.48 76.94 99 72
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 63.04%
# of Holders: 105
Total Shares Held: 65,920,738
3 Mo. Net Change: 9,612,942
# New Positions: 19
# Closed Positions: 15
# Increased Positions: 39
# Reduced Positions: 52
# Net Buyers: -13
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.